SCHEMBL3881960

SCHEMBL3881960

O=C(O)CCc1ccc(OCC2CCCC2)c(-c2ccc3cc(NC(=O)c4ccco4)ccc3c2)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
FFAR4 Q5NUL3 2/20 0.42
KMT2A Q03164 7/20 0.42
ALDH1A1 P00352 4/20 0.42
TSHR P16473 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
C5AR1 P21730 1/20 0.42
MAPK14 Q16539 1/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 5/20 0.41
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TP53 P04637 1/20 0.40
THRB P10828 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3883241 0.98 MAPT (0.41) MAPTFFAR4KMT2AALDH1A1TSHR
SCHEMBL3887482 0.92 MAPT (0.43) MAPTKMT2AALDH1A1TSHRNPC1
SCHEMBL3887894 0.90 KMT2A (0.42) MAPTKMT2AALDH1A1TSHRNPC1
SCHEMBL3892374 0.87 MAPT (0.42) MAPTKMT2AALDH1A1TSHRNPC1
SCHEMBL3882832 0.86 C5AR1 (0.46) FFAR4KMT2AC5AR1MEN1THRB
SCHEMBL3883616 0.86 C5AR1 (0.48) FFAR4KMT2AC5AR1MEN1THRB
SCHEMBL3681291 0.86 C5AR1 (0.46) FFAR4KMT2AC5AR1MEN1THRB
SCHEMBL3887449 0.84 MAPT (0.41) MAPTKMT2AALDH1A1TSHRNPC1
SCHEMBL3882142 0.84 C5AR1 (0.44) FFAR4KMT2AC5AR1MEN1THRB
SCHEMBL3883780 0.84 FFAR4 (0.46) FFAR4KMT2AC5AR1MEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 MAPT 4799/4885FFAR4 115/4885KMT2A 2392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.